ロード中...
Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
Chimeric antigen receptor T (CAR-T) cell therapy is an emerging and effective cancer immunotherapy. Especially in hematological malignancies, CAR-T cells have achieved exciting results. Two Anti-CD19 CAR-T therapies have been approved for the treatment of CD19-positive leukemia or lymphoma. However,...
保存先:
| 出版年: | Mol Cancer |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6701025/ https://ncbi.nlm.nih.gov/pubmed/31429760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-019-1057-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|